ArticlePloS one2021
Measurement and spatiotemporal analysis of high-quality development of China's industry.
Article in PloS one, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- An empirical study on key drivers of blind box online purchase experience based on online reviews: integrating the Kano model and entropy weight method.Scientific reports · 2026Article
- Article
- A pathway towards high-quality development of the manufacturing industry: Does scientific and technological talent matter?PloS one · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundChina's economy has been transitioning from a phase of rapid growth to high-quality development. The high-quality development of industry is the foundation of a sustainable and healthy growth of national economy, and is of great significance to improve people's living standards, and to meet people's needs for a better life.
methodsWe develop an evaluation index system of high-quality development of industry from the perspectives of industrial benefit, innovation ability, coordination ability, green ability, opening ability and sharing ability. Based on a panel data of 30 provinces in China during 1999-2018, we evaluate the level of high-quality development of industry using the entropy-weight method and Technique for Order Preference by Similarity to an Ideal Solution (TOPSIS) method. Meanwhile we select six specific years and adopt the Natural Breaks method to classify the provinces according to their levels. At last, Moran's I index is used to analyze the spatial correlation among the provinces.
resultsOpening ability and innovation ability are found to have greater impacts on industrial high-quality development than other indices, and their influence has been increasing in recent years. There are large spatial and temporal differences among different provinces. Municipalities and coastal provinces are found to be at constantly high levels. The levels in the central region dropped first and then increased, however it was the opposite in the western region. In the northeast region, the levels fluctuated greatly. Overall, the high-quality development of industry among China's provinces shows positive spatial correlation. Most provinces in China are in High-High and Low-Low clustering States. The High-High clustering type is mainly distributed in the eastern region and the Low-Low clustering type is mainly distributed in the western and central regions.
conclusion(1) Innovation ability and open ability are the most important factors. (2) Green ability has not sufficiently contributed to China's industrial development. (3) Regional and time evolution differences are significant. (4) There is a significant and stable spatial clustering effect in the high-quality development of industry among China's provinces.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.